Design and synthesis of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3- dihydroisobenzofuran-5-carbonitrile (citalopram) analogues as novel probes for the serotonin transporter S1 and S2 binding sites

Journal of Medicinal Chemistry

Volumn 56, Issue 23, 2013, Pages 9709-9724

  Banala, Ashwini K ^a   Zhang, Peng ^a   Plenge, Per ^b   Cyriac, George ^a   Kopajtic, Theresa ^a   Katz, Jonathan L ^a   Loland, Claus Juul ^b   Newman, Amy Hauck ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; SEROTONIN TRANSPORTER; SEROTONIN TRANSPORTER S1; SEROTONIN TRANSPORTER S2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; DRUG DESIGN; DRUG SYNTHESIS; MALE; NONHUMAN; RAT;

EID: 84890477885     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm4014136     Document Type: Article

References (39)

1. Kristensen, A. S.; Andersen, J.; Jorgensen, T. N.; Sorensen, L.; Eriksen, J.; Loland, C. J.; Stromgaard, K.; Gether, U. SLC6 neurotransmitter transporters: Structure, function, and regulation Pharmacol. Rev. 2011, 63, 585-640
2. Yamashita, A.; Singh, S. K.; Kawate, T.; Jin, Y.; Gouaux, E. Crystal structure of a bacterial homologue of Na+/Cl - dependent neurotransmitter transporters Nature 2005, 437, 215-223
3. Sorensen, L.; Andersen, J.; Thomsen, M.; Hansen, S. M.; Zhao, X.; Sandelin, A.; Stromgaard, K.; Kristensen, A. S. Interaction of antidepressants with the serotonin and norepinephrine transporters: Mutational studies of the S1 substrate binding pocket J. Biol. Chem. 2012, 287, 43694-43707
4. Andersen, J.; Stuhr-Hansen, N.; Zachariassen, L.; Toubro, S.; Hansen, S. M.; Eildal, J. N.; Bond, A. D.; Bogeso, K. P.; Bang-Andersen, B.; Kristensen, A. S.; Stromgaard, K. Molecular determinants for selective recognition of antidepressants in the human serotonin and norepinephrine transporters Proc. Natl. Acad. Sci. U. S. A. 2011, 108, 12137-12142
5. Andersen, J.; Olsen, L.; Hansen, K. B.; Taboureau, O.; Jorgensen, F. S.; Jorgensen, A. M.; Bang-Andersen, B.; Egebjerg, J.; Stromgaard, K.; Kristensen, A. S. Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter J. Biol. Chem. 2010, 285, 2051-2063
6. Andersen, J.; Taboureau, O.; Hansen, K. B.; Olsen, L.; Egebjerg, J.; Stromgaard, K.; Kristensen, A. S. Location of the antidepressant binding site in the serotonin transporter: Importance of Ser-438 in recognition of citalopram and tricyclic antidepressants J. Biol. Chem. 2009, 284, 10276-10284
7. Eildal, J. N.; Andersen, J.; Kristensen, A. S.; Jorgensen, A. M.; Bang-Andersen, B.; Jorgensen, M.; Stromgaard, K. From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: Synthesis and structure-activity relationship studies J. Med. Chem. 2008, 51, 3045-3048
8. Zhang, P.; Cyriac, G.; Kopajtic, T.; Zhao, Y.; Javitch, J. A.; Katz, J. L.; Newman, A. H. Structure-activity relationships for a novel series of citalopram (1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3- dihydroisobenzofuran-5-carbon itrile) analogues at monoamine transporters J. Med. Chem. 2010, 53, 6112-6121
9. Singh, S. K.; Yamashita, A.; Gouaux, E. Antidepressant binding site in a bacterial homologue of neurotransmitter transporters Nature 2007, 448, 952-956
10. Zhou, Z.; Zhen, J.; Karpowich, N. K.; Goetz, R. M.; Law, C. J.; Reith, M. E.; Wang, D. N. LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake Science 2007, 317, 1390-1393
11. Zhou, Z.; Zhen, J.; Karpowich, N. K.; Law, C. J.; Reith, M. E.; Wang, D. N. Antidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structures Nat. Struct. Mol. Biol. 2009, 16, 652-657
12. Zhao, Y.; Terry, D. S.; Shi, L.; Quick, M.; Weinstein, H.; Blanchard, S. C.; Javitch, J. A. Substrate-modulated gating dynamics in a Na+-coupled neurotransmitter transporter homologue Nature 2011, 474, 109-113
13. Quick, M.; Shi, L.; Zehnpfennig, B.; Weinstein, H.; Javitch, J. A. Experimental conditions can obscure the second high-affinity site in LeuT Nat. Struct. Mol. Biol. 2012, 19, 207-211
14. Koldso, H.; Severinsen, K.; Tran, T. T.; Celik, L.; Jensen, H. H.; Wiborg, O.; Schiott, B.; Sinning, S. The two enantiomers of citalopram bind to the human serotonin transporter in reversed orientations J. Am. Chem. Soc. 2010, 132, 1311-1322
15. Sinning, S.; Musgaard, M.; Jensen, M.; Severinsen, K.; Celik, L.; Koldso, H.; Meyer, T.; Bols, M.; Jensen, H. H.; Schiott, B.; Wiborg, O. Binding and orientation of tricyclic antidepressants within the central substrate site of the human serotonin transporter J. Biol. Chem. 2010, 285, 8363-8374
16. Henry, L. K.; Field, J. R.; Adkins, E. M.; Parnas, M. L.; Vaughan, R. A.; Zou, M. F.; Newman, A. H.; Blakely, R. D. Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants J. Biol. Chem. 2006, 281, 2012-2023
17. Wennogle, L. P.; Meyerson, L. R. Serotonin modulates the dissociation of [3H]imipramine from human platelet recognition sites Eur. J. Pharmacol. 1982, 86, 303-307
18. Plenge, P.; Mellerup, E. T. Antidepressive drugs can change the affinity of [3H]imipramine and [3H]paroxetine binding to platelet and neuronal membranes Eur. J. Pharmacol. 1985, 119, 1-8
19. Plenge, P.; Mellerup, E. T.; Laursen, H. Affinity modulation of [3H]imipramine, [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and platelets Eur. J. Pharmacol. 1991, 206, 243-250
20. Plenge, P.; Mellerup, E. T. An affinity-modulating site on neuronal monoamine transport proteins Pharmacol. Toxicol. 1997, 80, 197-201
21. Chen, F.; Larsen, M. B.; Neubauer, H. A.; Sanchez, C.; Plenge, P.; Wiborg, O. Characterization of an allosteric citalopram-binding site at the serotonin transporter J. Neurochem. 2005, 92, 21-28
22. Zhong, H.; Haddjeri, N.; Sanchez, C. Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter-a review of current understanding of its mechanism of action Psychopharmacology (Berlin, Ger.) 2012, 219, 1-13
23. Plenge, P.; Gether, U.; Rasmussen, S. G. Allosteric effects of R- and S-citalopram on the human 5-HT transporter: evidence for distinct high- and low-affinity binding sites Eur. J. Pharmacol. 2007, 567, 1-9
24. Zhong, H.; Hansen, K. B.; Boyle, N. J.; Han, K.; Muske, G.; Huang, X.; Egebjerg, J.; Sanchez, C. An allosteric binding site at the human serotonin transporter mediates the inhibition of escitalopram by R-citalopram: Kinetic binding studies with the ALI/VFL-SI/TT mutant Neurosci. Lett. 2009, 462, 207-212
25. Neubauer, H. A.; Hansen, C. G.; Wiborg, O. Dissection of an allosteric mechanism on the serotonin transporter: A cross-species study Mol. Pharmacol. 2006, 69, 1242-1250
26. Chen, F.; Larsen, M. B.; Sanchez, C.; Wiborg, O. The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors Eur. Neuropsychopharmacol. 2005, 15, 193-198
27. Plenge, P.; Shi, L.; Beuming, T.; Te, J.; Newman, A. H.; Weinstein, H.; Gether, U.; Loland, C. J. Steric hindrance mutagenesis in the conserved extracellular vestibule impedes allosteric binding of antidepressants to the serotonin transporter J. Biol. Chem. 2012, 287, 39316-39326
28. Sarker, S.; Weissensteiner, R.; Steiner, I.; Sitte, H. H.; Ecker, G. F.; Freissmuth, M.; Sucic, S. The high-affinity binding site for tricyclic antidepressants resides in the outer vestibule of the serotonin transporter Mol. Pharmacol. 2010, 78, 1026-1035
29. Wang, H.; Gouaux, E. Substrate binds in the S1 site of the F253A mutant of LeuT, a neurotransmitter sodium symporter homologue EMBO Rep. 2012, 13, 861-8666
30. Bigler, A. J.; Bogeso, K. P.; Toft, A.; Hansed, V. Quantitative structure-activity relationships in a series of selective 5-HT uptake inhibitors Eur. J. Med. Chem.. 1977, 12, 289-295
31. Siracusa, M. A.; Salerno, L.; Modica, M. N.; Pittalà, V.; Romeo, G.; Amato, M. E.; Nowak, M.; Bojarski, A. J.; Mereghetti, I.; Cagnotto, A.; Mennini, T. Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands J. Med. Chem. 2008, 51, 4529-4538
32. Newman, A. H.; Grundt, P.; Cyriac, G.; Deschamps, J. R.; Taylor, M.; Kumar, R.; Ho, D.; Luedtke, R. R. N -(4-(4-(2,3-Dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with functionalized linking chains as high affinity and enantioselective D3 receptor antagonists J. Med. Chem. 2009, 52, 2559-2570
33. Deskus, J. A.; Epperson, J. R.; Sloan, C. P.; Cipollina, J. A.; Dextraze, P.; Qian-Cutrone, J.; Gao, Q.; Ma, B.; Beno, B. R.; Mattson, G. K.; Molski, T. F.; Krause, R. G.; Taber, M. T.; Lodge, N. J.; Mattson, R. J. Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors Bioorg. Med. Chem. Lett. 2007, 17, 3099-3104
34. Bogeso, K.; Sanchez, C. The Discovery of Citalopram and its Refinement to Escitalopram. In Analogue-based Drug Discovery III, 1 st ed.; Fischer, C.; Ganellin, R.; Rotella, D. P., Eds.; Wiley-VCH Verlag GmbH & Co.: Weinheim, Germany, 2013; pp 269-294.
35. Xu, L.; Izenwasser, S.; Katz, J. L.; Kopajtic, T.; Klein-Stevens, C.; Zhu, N.; Lomenzo, S. A.; Winfield, L.; Trudell, M. L. Synthesis and biological evaluation of 2-substituted 3beta-tolyltropane derivatives at dopamine, serotonin, and norepinephrine transporters J. Med. Chem. 2002, 45, 1203-1210
36. Zhang, P.; Jorgensen, T. J.; Loland, C. J.; Newman, A. H. A rhodamine-labeled citalopram analogue as a high-affinity fluorescent probe for the serotonin transporter Bioorg. Med. Chem. Lett. 2013, 23, 323-326
37. Biessen, E. A.; Horn, A. S.; Robillard, G. T. Partial purification of the 5-hydroxytryptamine-reuptake system from human blood platelts using citalopram-derived affinity resin Biochemistry 1990, 29, 3349-3354
38. Rasmussen, S. G.; Gether, U. Purification and fluorescent labeling of the human serotonin transporter Biochemistry 2005, 44, 3494-3505
39. Beuming, T.; Bergmann, M. L.; Shi, L.; Gracia, L.; Raniszewska, K.; Newman, A. H.; Javitch, J. A.; Weinstein, H.; Gether, U.; Loland, C. J. Mapping of the binding sites for cocaine and dopamine in the dopamine transporter Nat. Neurosci. 2008, 11, 780-789